BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32291827)

  • 1. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors.
    Zhang Z; Mäkinen N; Kasai Y; Kim GE; Diosdado B; Nakakura E; Meyerson M
    Genes Chromosomes Cancer; 2020 Sep; 59(9):535-539. PubMed ID: 32291827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors.
    Wang GG; Yao JC; Worah S; White JA; Luna R; Wu TT; Hamilton SR; Rashid A
    Mod Pathol; 2005 Aug; 18(8):1079-87. PubMed ID: 15920555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
    Mäkinen N; Zhou M; Zhang Z; Kasai Y; Perez E; Kim GE; Thirlwell C; Nakakura E; Meyerson M
    Genome Med; 2022 Aug; 14(1):82. PubMed ID: 35922826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.
    Walsh KM; Choi M; Oberg K; Kulke MH; Yao JC; Wu C; Jurkiewicz M; Hsu LI; Hooshmand SM; Hassan M; Janson ET; Cunningham JL; Vosburgh E; Sackler RS; Lifton RP; Dewan AT; Hoh J
    Endocr Relat Cancer; 2011 Feb; 18(1):171-80. PubMed ID: 21139019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms.
    Bottarelli L; Azzoni C; Pizzi S; D'Adda T; Silini EM; Bordi C; Rindi G
    Hum Pathol; 2013 Dec; 44(12):2736-42. PubMed ID: 24139208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors.
    Bollard J; Massoma P; Vercherat C; Blanc M; Lepinasse F; Gadot N; Couderc C; Poncet G; Walter T; Joly MO; Hervieu V; Scoazec JY; Roche C
    Oncotarget; 2015 Nov; 6(34):36731-45. PubMed ID: 26447612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex.
    Geis C; Fendrich V; Rexin P; Di Fazio P; Bartsch DK; Ocker M; Quint K; Heverhagen AE
    J Surg Res; 2015 Apr; 194(2):388-393. PubMed ID: 25439321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors.
    Sei Y; Feng J; Zhao X; Forbes J; Tang D; Nagashima K; Hanson J; Quezado MM; Hughes MS; Wank SA
    Gastroenterology; 2016 Jul; 151(1):140-51. PubMed ID: 27003604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.
    Nieser M; Henopp T; Brix J; Stoß L; Sitek B; Naboulsi W; Anlauf M; Schlitter AM; Klöppel G; Gress T; Moll R; Bartsch DK; Heverhagen AE; Knoefel WT; Kaemmerer D; Haybaeck J; Fend F; Sperveslage J; Sipos B
    Neuroendocrinology; 2017; 104(3):302-312. PubMed ID: 27222126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors.
    Kim DH; Nagano Y; Choi IS; White JA; Yao JC; Rashid A
    Genes Chromosomes Cancer; 2008 Jan; 47(1):84-92. PubMed ID: 17943967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tumour with a neuroendocrine and papillary serous component: two or a pair?
    Van Eeden S; Nederlof PM; Taal BG; Offerhaus GJ; Van Velthuysen ML
    J Clin Pathol; 2002 Sep; 55(9):710-4. PubMed ID: 12195006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evidence for independent origin of multifocal neuroendocrine tumors of the enteropancreatic axis.
    Katona TM; Jones TD; Wang M; Abdul-Karim FW; Cummings OW; Cheng L
    Cancer Res; 2006 May; 66(9):4936-42. PubMed ID: 16651451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of robust controls for the normalization of miRNA expression in neuroendocrine tumors of the ileum and pancreas.
    Sperveslage J; Hoffmeister M; Henopp T; Klöppel G; Sipos B
    Endocrine; 2014 Jun; 46(2):226-30. PubMed ID: 24535468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors.
    Cunningham JL; Díaz de Ståhl T; Sjöblom T; Westin G; Dumanski JP; Janson ET
    Genes Chromosomes Cancer; 2011 Feb; 50(2):82-94. PubMed ID: 21104784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
    Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
    Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids.
    Andersson E; Swärd C; Stenman G; Ahlman H; Nilsson O
    Endocr Relat Cancer; 2009 Sep; 16(3):953-66. PubMed ID: 19458023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
    Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.
    Byun S; Affolter KE; Snow AK; Curtin K; Cannon AR; Cannon-Albright LA; Thota R; Neklason DW
    Sci Rep; 2021 Jun; 11(1):12303. PubMed ID: 34112938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.